Charles A. Bancroft's Insider Trades & SAST Disclosures
Charles A. Bancroft's most recent trade in GSK Plc - ADR was a trade of 348 Ords 0.31p done at an average price of $17.1 . Disclosure was reported to the exchange on April 11, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Charles A. Bancroft.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GSK Plc - ADR | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 17.06 per share. | 11 Apr 2025 | 348 | 84,457 (0%) | 0% | 17.1 | 5,937 | Ords 0.31p |
| GSK Plc - ADR | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 38.81 per share. | 25 Mar 2025 | 15,843 | 84,109 (0%) | 0% | 38.8 | 614,788 | Ords 0.31p |
| GSK Plc - ADR | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 19.64 per share. | 20 Mar 2025 | 3,938 | 68,266 (0%) | 0% | 19.6 | 77,331 | Ords 0.31p |
| GSK Plc - ADR | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Sale or transfer of securities back to the company at price $ 16.68 per share. | 10 Jan 2025 | 278 | 62,818 (0%) | 0% | 16.7 | 4,636 | Ords 0.31p |
| GSK Plc - ADR | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 16.90 per share. | 20 Dec 2024 | 4,368 | 62,540 (0%) | 0% | 16.9 | 73,840 | Ords 0.31p |
| GSK Plc - ADR | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Sale or transfer of securities back to the company at price $ 19.53 per share. | 11 Oct 2024 | 210 | 58,172 (0%) | 0% | 19.5 | 4,101 | Ords 0.31p |
| GSK Plc - ADR | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 20.51 per share. | 23 Sep 2024 | 3,602 | 57,962 (0%) | 0% | 20.5 | 73,862 | Ords 0.31p |
| GSK Plc - ADR | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Sale or transfer of securities back to the company at price $ 19.67 per share. | 12 Jul 2024 | 168 | 54,360 (0%) | 0% | 19.7 | 3,304 | Ords 0.31p |
| Kodiak Sciences Inc | Charles A. Bancroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| GSK Plc - ADR | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 20.38 per share. | 20 Jun 2024 | 3,622 | 54,192 (0%) | 0% | 20.4 | 73,825 | Ords 0.31p |
| GSK Plc - ADR | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 20.48 per share. | 12 Apr 2024 | 136 | 50,570 (0%) | 0% | 20.5 | 2,785 | Ords 0.31p |
| GSK Plc - ADR | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 20.95 per share. | 20 Mar 2024 | 3,306 | 50,434 (0%) | 0% | 21.0 | 69,265 | Ords 0.31p |
| GSK Plc - ADR | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 20.05 per share. | 12 Jan 2024 | 92 | 45,710 (0%) | 0% | 20.1 | 1,845 | Ords 0.31p |
| Kodiak Sciences Inc | Charles A. Bancroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Kodiak Sciences Inc | Charles A. Bancroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Kodiak Sciences Inc | Charles A. Bancroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 7,368 | 7,368 | - | - | Stock Option (Right to Buy) | |
| Kodiak Sciences Inc | Charles A. Bancroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 2,104 | 2,104 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges